Quest Diagnostics (DGX) Insider Trading & Ownership $160.39 +3.55 (+2.26%) (As of 11/15/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Quest Diagnostics (NYSE:DGX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.79%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$5.69 M Get DGX Insider Trade Alerts Want to know when executives and insiders are buying or selling Quest Diagnostics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address DGX Insider Buying and Selling by Quarter Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Quest Diagnostics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/6/2024Michael J DeppeCAOSell18,755$154.05$2,889,207.75 10/28/2024Karthik KuppusamySVPSell1,775$156.92$278,533.00 8/28/2024Karthik KuppusamySVPSell1,990$153.26$304,987.40 7/24/2024Mark E DelaneySVPSell420$143.08$60,093.60 4/29/2024Karthik KuppusamySVPSell1,760$140.00$246,400.00 4/4/2024Earl BlumenauerU.S. Congress Member (D-OR)Sell$131.50$1,001 - $15,0002/29/2024Michael E PrevoznikSVPSell5,611$125.88$706,312.68 “Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late.2/28/2024Catherine T DohertyEVPSell5,557$126.57$703,349.49 2/23/2024Vicky B GreggDirectorSell2,500$126.64$316,600.00 2/22/2024Catherine T DohertyEVPSell821$126.14$103,560.94 2/22/2024Michael E PrevoznikSVPSell661$126.14$83,378.54 (Data available from 1/1/2013 forward) DGX Insider Trading Activity - Frequently Asked Questions Who is on Quest Diagnostics's Insider Roster? The list of insiders at Quest Diagnostics includes Catherine T Doherty, Karthik Kuppusamy, Mark E Delaney, Michael E Prevoznik, Michael J Deppe, Stephen H Rusckowski, Timothy M Ring, and Vicky B Gregg. Learn more on insiders at DGX. What percentage of Quest Diagnostics stock is owned by insiders? 0.79% of Quest Diagnostics stock is owned by insiders. Learn more on DGX's insider holdings. Which Quest Diagnostics insiders have been selling company stock? The following insiders have sold DGX shares in the last 24 months: Catherine T Doherty ($6,888,233.13), Karthik Kuppusamy ($829,920.40), Mark E Delaney ($60,093.60), Michael E Prevoznik ($989,800.52), Michael J Deppe ($2,889,207.75), Timothy M Ring ($308,812.50), and Vicky B Gregg ($316,600.00). How much insider selling is happening at Quest Diagnostics? Insiders have sold a total of 84,055 Quest Diagnostics shares in the last 24 months for a total of $12,282,667.90 sold. Which members of congress are trading Quest Diagnostics? Earl Blumenauer (D-OR), Tommy Tuberville (R-AL), and Thomas R. Carper (D-DE) have sold shares of Quest Diagnostics in the last year totaling $48,500. Quest Diagnostics Key ExecutivesMr. James E. Davis (Age 61)Chairman, CEO & President Compensation: $2.88MMr. Sam A. Samad (Age 54)Executive VP & CFO Compensation: $1.33MMr. Michael E. Prevoznik (Age 62)Senior VP & General Counsel Compensation: $881.23kMs. Catherine T. Doherty (Age 61)Executive Vice President of Regional Businesses Compensation: $1MMr. Karthik Kuppusamy Ph.D. (Age 54)Senior Vice President of Clinical Solutions Compensation: $840.3k2 recent tradesMr. Michael J. Deppe (Age 57)Senior VP, Corporate Controller & Chief Accounting Officer 1 recent tradesMr. Murali BalakumarSenior VP, Chief Information & Digital OfficerMr. Shawn C. BevecVice President of Investor RelationsMs. Kristin Lee Wallace Esq.Senior VP & Chief Compliance OfficerMr. Gary D. SamuelsSenior VP & Chief Communications Officer More Insider Trading Tools from MarketBeat Related Companies Laboratory Co. of America Insider Trades DaVita Insider Trades Chemed Insider Trades R1 RCM Insider Trades CorVel Insider Trades Amedisys Insider Trades Pediatrix Medical Group Insider Trades AMN Healthcare Services Insider Trades Cross Country Healthcare Insider Trades Natera Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics Partners This page (NYSE:DGX) was last updated on 11/16/2024 by MarketBeat.com Staff From Our PartnersTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this BEFORE November 19th.Brownstone Research | Sponsored🗓️ My First LIVE Event in 5 Years!Give us 60 minutes and we’ll show you how we’ve compressed 15 years of stock market gains into one day.Behind the Markets | SponsoredElon Musk’s $30 Billion Trump Bet Pays Off—What’s Next?Elon Musk bet big on Trump's victory, and that gamble has already added over $30 billion to his net worth in a...InvestorPlace | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | SponsoredBreaking News: Are Trump/Musk Planning an AI Takeover? (Shocking)Now that he is Donald Trump’s right-hand man… You owe it to yourself to see Elon Musk’s big AI prediction f...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quest Diagnostics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Quest Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
